Sean Doherty
2023 ALI Fellow

Sean Doherty brings to ALI leadership in disease philanthropy innovation, law and finance. He is the founder and chair emeritus of the T1D Fund, an impact investment fund that has used a venture philanthropic model to catalyze over $700 million of private capital investment in type one diabetes cure therapeutics. He has recently founded T1D Action, which will use the power of narrative to drive better care for people living with T1D.

Sean is a former managing director of Bain Capital, a leading global alternative investment firm. As the firm’s first general counsel, he built an industry-leading legal, compliance and public affairs group and led a variety of efforts in crisis management, branding, and philanthropy. He is a veteran of the United States Navy.